VANIA FRANCOIS: Open Payments
NPI 1184348740 · ROCKY MOUNT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 16 payments from 8 companies in 2025. Trend: 2023 $743 · 2024 $1,387 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Novo Nordisk Inc | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Amgen Inc. | 3 | $45 |
| Corcept Therapeutics | 1 | $25 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: FARXIGA, TRELEGY ELLIPTA, OTEZLA, Ozempic, Korlym, Wegovy, CONTRAVE, Kerendia.
Industry payments across NC — which companies pay providers there.
